BlackRock Investment Management, LLC - RXI PHARMACEUTICALS CORP NEW ownership

Back to all holdings Add to watchlist

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 21 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q1 2015$2,000
-50.0%
2,7010.0%0.00%–
Q4 2014$4,0000.0%2,701
+40.4%
0.00%–
Q3 2014$4,000
-33.3%
1,9240.0%0.00%–
Q2 2014$6,000–1,924–0.00%–
 Download
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q2 2015.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders